Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Faron Pharmaceuticals Oy · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $7.74M | $7.74M - $7.74M | $0.00 | -$0.248 | 3 |
| Dec 2029 | $518.0K | $518.0K - $518.0K | $0.00 | -$0.112 | 3 |
| Dec 2028 | $21.78M | $21.78M - $21.78M | $0.00 | -$0.044 | 2 |
| Dec 2027 | $998.00 | $998.00 - $998.00 | $0.00 | -$0.157 | 4 |
| Dec 2026 | $998.00 | $998.00 - $998.00 | $0.00 | -$0.126 | 3 |
| Dec 2025 | $1.0K | $1.0K - $1.0K | $0.00 | -$0.232 | 5 |
| Dec 2024 | $2.0K | $2.0K - $2.0K | $0.00 | -$0.307 | 3 |
| Dec 2021 | $2.90M | $2.90M - $2.90M | $0.00 | -$0.302 | 1 |
| Dec 2018 | $20.2K | $20.2K - $20.2K | $0.00 | -$0.518 | 1 |
| Dec 2017 | $10.1K | $10.1K - $10.1K | $0.00 | -$0.607 | 2 |
| Dec 2016 | $1.17M | $1.17M - $1.17M | $0.00 | -$0.306 | 1 |